Literature DB >> 24681107

Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism.

Zhidong Yan1, Yongxun Zhuansun1, Rui Chen1, Jianguo Li2, Pixin Ran3.   

Abstract

Mesenchymal stromal cells (MSCs) and regulatory T cells (Tregs) have both garnered abundant interests from immunologists worldwide, as both MSCs and Tregs can be considered immunosuppressive in their own right. But a little attention has been paid to the impacts of MSCs on Tregs. To clarify the effects of MSCs on Tregs, we performed the coculture systems within MSCs and Tregs. We confirmed that MSC-exposed Tregs are capable of more immunosuppressive than Tregs without coculturing with MSCs. And this augmenting suppressive capacity was accompanied with an upregulation of programmed cell death 1 receptor (PD-1) on Tregs. Importantly, we found that cell viability of Tregs was excluded from the influences of MSCs. Finally, we showed that PD-1/B7-H1 interactions and IL-10 might be responsible for the enhanced suppressive capability of MSC-exposed Tregs. Further analysis revealed that PD-1/B7-H1 interactions were not responsible for the productions of IL-10 and TGF-β1 in the MSC-Treg coculture systems; in contrast, IL-10 rather than TGF-β1 played a role in the upregualtion of PD-1. Furthermore, this is the first explorative study to evaluate the immunomodulation of MSCs on the suppressive capacity of Tregs in MSC-Treg in vitro coculture setting.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immunomodulation; Mesenchymal stromal cells; Programmed cell death 1 receptor; Regulatory T cells

Mesh:

Substances:

Year:  2014        PMID: 24681107     DOI: 10.1016/j.yexcr.2014.03.013

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  36 in total

Review 1.  Targeting Endogenous Repair Pathways after AKI.

Authors:  Benjamin D Humphreys; Vincenzo Cantaluppi; Didier Portilla; Kai Singbartl; Li Yang; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-11-18       Impact factor: 10.121

2.  Immunomodulation of endothelial differentiated mesenchymal stromal cells: impact on T and NK cells.

Authors:  Reine El Omar; Yu Xiong; Gabriel Dostert; Huguette Louis; Monique Gentils; Patrick Menu; Jean-François Stoltz; Émilie Velot; Véronique Decot
Journal:  Immunol Cell Biol       Date:  2015-10-29       Impact factor: 5.126

3.  Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD.

Authors:  Sabine Geiger; Emrah I Ozay; Ulf Geumann; Marina K Hereth; Terese Magnusson; Sudarvili Shanthalingam; Daniela Hirsch; Stefanie Kälin; Christine Günther; Barbara A Osborne; Gregory N Tew; Felix G Hermann; Lisa M Minter
Journal:  Mol Ther       Date:  2019-05-16       Impact factor: 11.454

4.  Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth.

Authors:  Huilin Zheng; Weibin Zou; Jiaying Shen; Liang Xu; Shu Wang; Yang-Xin Fu; Weimin Fan
Journal:  Stem Cells Transl Med       Date:  2016-06-28       Impact factor: 6.940

Review 5.  Fracture healing: mechanisms and interventions.

Authors:  Thomas A Einhorn; Louis C Gerstenfeld
Journal:  Nat Rev Rheumatol       Date:  2014-09-30       Impact factor: 20.543

Review 6.  Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?

Authors:  Martha L Arango-Rodriguez; Fernando Ezquer; Marcelo Ezquer; Paulette Conget
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

7.  Co-transplantation of syngeneic mesenchymal stem cells improves survival of allogeneic glial-restricted precursors in mouse brain.

Authors:  Amit K Srivastava; Camille A Bulte; Irina Shats; Piotr Walczak; Jeff W M Bulte
Journal:  Exp Neurol       Date:  2015-10-26       Impact factor: 5.330

Review 8.  Biological Therapies in Regenerative Sports Medicine.

Authors:  Isabel Andia; Nicola Maffulli
Journal:  Sports Med       Date:  2017-05       Impact factor: 11.136

Review 9.  Advances in islet encapsulation technologies.

Authors:  Tejal Desai; Lonnie D Shea
Journal:  Nat Rev Drug Discov       Date:  2016-12-23       Impact factor: 84.694

Review 10.  Tissue Engineering Approaches to Modulate the Inflammatory Milieu following Spinal Cord Injury.

Authors:  Courtney M Dumont; Daniel J Margul; Lonnie D Shea
Journal:  Cells Tissues Organs       Date:  2016-10-05       Impact factor: 2.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.